041830 — InBody Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Market Cap
KR₩380bn
Enterprise Value
KR₩290bn
Revenue
KR₩204bn

Annual balance sheet for InBody Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	57,491	71,429	86,546	98,915	103,629
Net Total Accounts Receivable
Net Total Receivables	8,760	17,398	18,153	17,489	25,291
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	84,351	110,110	135,489	148,964	171,374
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	69,278	75,835	81,731	85,909	91,465
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	166,150	203,760	242,665	274,456	305,817
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11,113	16,253	19,205	17,451	25,823
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	16,085	20,025	27,405	25,690	32,851
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	150,065	183,735	215,260	248,766	272,966
Total Liabilities & Shareholders' Equity	166,150	203,760	242,665	274,456	305,817
Total Common Shares Outstanding